导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -2.27% | 2923/4773 |
| 近一周 | -1.89% | 3692/5467 |
| 近一月 | -10.98% | 4908/5421 |
| 近一季 | -16.04% | 4272/5238 |
| 近半年 | -1.64% | 2027/4931 |
| 近一年 | -1.80% | 2897/4400 |
| 近两年 | 76.24% | 890/2954 |
| 近三年 | 48.98% | 564/2253 |
| 成立以来 | 84.11% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.81% 2921/4961 |
20.91% 1199/5312 |
- - |
- - |
| 2025 | 38.71% 861/4813 |
0.88% 1748/3635 |
0.41% 2666/4076 |
41.05% 739/4524 |
-2.91% 3226/4813 |
| 2024 | 18.21% 615/3463 |
-0.63% 1133/2808 |
-2.54% 1201/3014 |
22.65% 455/3129 |
-0.48% 1436/3463 |
| 2023 | -17.92% 1769/2656 |
3.31% 1219/2280 |
-5.41% 1445/2385 |
-9.70% 1880/2515 |
-6.98% 2003/2655 |
| 2022 | -27.32% 1468/2207 |
-19.82% 1497/1919 |
10.75% 255/2016 |
-19.58% 1789/2113 |
1.78% 1144/2208 |
| 2021 | 2.16% 636/1822 |
-8.42% 1084/1255 |
16.60% 199/1330 |
-7.65% 1069/1466 |
3.59% 419/1822 |
| 2020 | 62.20% 118/1250 |
0.26% 165/1028 |
23.98% 181/1067 |
10.93% 494/1164 |
17.63% 115/1184 |
| 2019 | - - |
- - |
- - |
- - |
9.82% 189/918 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4796 | 32.41% |
| 港股通药 | 0.9109 | 32.37% |
| 万家中证港股通创新药ETF | 1.6293 | 32.25% |
| 景顺长城中证港股通创新药ETF | 1.6918 | 32.17% |
| 天弘恒生沪深港创新药精选50ETF | 0.8599 | 32.08% |
| 港股医疗 | 0.9703 | 31.90% |
| 港医疗 | 0.9212 | 31.83% |
| 港股通医疗ETF工银 | 0.9798 | 31.81% |
| 港股通医疗ETF华宝 | 0.9918 | 31.64% |
| 万家中证港股通创新药ETF发起式联接A | 1.4193 | 31.06% |
| 弘毅远方民企领先100ETF VS. 长安沪深300非周期A(740101) |